Immune Dysregulation (Behrens 2024)
Inflammation, recurrent infections, fevers and rashes, and poor growth may all be ways that immune dysregulation presents in primary care patients. Edward Behrens, MD, Chief…
Inflammation, recurrent infections, fevers and rashes, and poor growth may all be ways that immune dysregulation presents in primary care patients. Edward Behrens, MD, Chief…
At the end of this session, learners will be able to understand the process, architecture, manufacture, and trials of chimeric antigen receptor (CAR) T-cells. Speaker:…
For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending…
E. John Wherry, PhD, is the Barbara and Richard Schiffrin President’s Distinguished Professor, Chair of the Department of Systems Pharmacology and Translational Therapeutics in the…
At the end of this session, learners will be able to understand what is and what is not immune dysregulation, as well as options for…
At the end of this session, learners will be able to understand definitive therapies for immunodeficiency and the workflow for utilization of definitive therapies with…
At the end of this session, learners will be able to discuss the medical management of pediatric patients with immunodeficiency through utilization of immunoglobulin replacement,…
At the end of this session, learners will be able to understand the history of genetic testing, recall commonly used forms of genetic testing for…
At the end of this session, learners will be able to describe an overall approach to evaluation for primary immunodeficiency, including the utilization of functional…
At the end of this session, learners will be able to understand the background, epidemiology, and prevalence of Immunoglobulin E (IgE) Mediated Food Allergy (FA),…